Oncology
Carcinoma
3
Pipeline Programs↗
7
Active Trials↗
12
Companies Involved↗
Carcinoma is an early-stage landscape with 3 programs across 12 companies. The most active players are Hikma Pharmaceuticals LLC, GSK, Japanese Gynecologic Oncology Group.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical2
Phase 1
No programs
Phase 21
Phase 3
No programs
Approved
No programs
Analysis
Trial Status
47
clinical trials
Completed22 · 47%
Unknown status8 · 17%
Terminated6 · 13%
Recruiting4 · 9%
Withdrawn3 · 6%
Active, not recruiting2 · 4%
Other2 · 4%
Clinical Trials
Trial Activity
47 trials
Addition of Everolimus to Standard of Care in Carcinoma Gallbladder
Recruiting·—·Phase 2/3·NCT05833815·56 enrolled
A Clinical Study of TQB3454 Tablets in the Treatment of Advanced Biliary Carcinoma.
Active, not recruiting·
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.·Phase 3·NCT05987358·165 enrolled
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.·Phase 3·NCT05987358·165 enrolledPage 1 of 4
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)